Investigating statistical epistasis in complex disorders

James C. Turton, James Bullock, Christopher Medway, Hui Shi, Kristelle Brown, Olivia Belbin, Noor Kalsheker, Minerva M Carrasquillo, Dennis W Dickson, Neill R Graff Radford, Ronald Carl Petersen, Steven G Younkin, Kevin Morgan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The missing heritability exhibited by late-onset Alzheimer's disease is unexplained and has been partly attributed to epistatic interaction. Methods available to explore this are often based on logistic regression and allow for determination of deviation from an expected outcome as a result of statistical epistasis. Three such methodologies including Synergy Factor and the PLINK modules,-epistasis and-fast-epistasis, were applied to study an epistatic interaction between interleukin-6 and interleukin-10. The models analyzed consisted of two synergistic interactions (SF ≈ 4.2 and 1.6) and two antagonistic interactions (SF ≈ 0.9 and 0.6). As with any statistical test, power to detect association is paramount; and most studies will be underpowered for the task. However, the availability of large sample sizes through genome-wide association studies make it feasible to examine approaches for determining epistatic interactions. This study documents the sample sizes needed to achieve a statistically significant outcome from each of the methods examined and discusses the limitations/advantages of the chosen approaches.

Original languageEnglish (US)
Pages (from-to)635-644
Number of pages10
JournalJournal of Alzheimer's Disease
Volume25
Issue number4
DOIs
StatePublished - 2011

Fingerprint

Sample Size
Genome-Wide Association Study
Interleukin-10
Interleukin-6
Alzheimer Disease
Logistic Models
Power (Psychology)

Keywords

  • Complex disorders
  • epistasis
  • LOAD
  • modeling
  • PLINK
  • synergy factor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Turton, J. C., Bullock, J., Medway, C., Shi, H., Brown, K., Belbin, O., ... Morgan, K. (2011). Investigating statistical epistasis in complex disorders. Journal of Alzheimer's Disease, 25(4), 635-644. https://doi.org/10.3233/JAD-2011-110197

Investigating statistical epistasis in complex disorders. / Turton, James C.; Bullock, James; Medway, Christopher; Shi, Hui; Brown, Kristelle; Belbin, Olivia; Kalsheker, Noor; Carrasquillo, Minerva M; Dickson, Dennis W; Graff Radford, Neill R; Petersen, Ronald Carl; Younkin, Steven G; Morgan, Kevin.

In: Journal of Alzheimer's Disease, Vol. 25, No. 4, 2011, p. 635-644.

Research output: Contribution to journalArticle

Turton JC, Bullock J, Medway C, Shi H, Brown K, Belbin O et al. Investigating statistical epistasis in complex disorders. Journal of Alzheimer's Disease. 2011;25(4):635-644. https://doi.org/10.3233/JAD-2011-110197
Turton, James C. ; Bullock, James ; Medway, Christopher ; Shi, Hui ; Brown, Kristelle ; Belbin, Olivia ; Kalsheker, Noor ; Carrasquillo, Minerva M ; Dickson, Dennis W ; Graff Radford, Neill R ; Petersen, Ronald Carl ; Younkin, Steven G ; Morgan, Kevin. / Investigating statistical epistasis in complex disorders. In: Journal of Alzheimer's Disease. 2011 ; Vol. 25, No. 4. pp. 635-644.
@article{15a5fb65746e4f35a0d5dd8ab3e499d9,
title = "Investigating statistical epistasis in complex disorders",
abstract = "The missing heritability exhibited by late-onset Alzheimer's disease is unexplained and has been partly attributed to epistatic interaction. Methods available to explore this are often based on logistic regression and allow for determination of deviation from an expected outcome as a result of statistical epistasis. Three such methodologies including Synergy Factor and the PLINK modules,-epistasis and-fast-epistasis, were applied to study an epistatic interaction between interleukin-6 and interleukin-10. The models analyzed consisted of two synergistic interactions (SF ≈ 4.2 and 1.6) and two antagonistic interactions (SF ≈ 0.9 and 0.6). As with any statistical test, power to detect association is paramount; and most studies will be underpowered for the task. However, the availability of large sample sizes through genome-wide association studies make it feasible to examine approaches for determining epistatic interactions. This study documents the sample sizes needed to achieve a statistically significant outcome from each of the methods examined and discusses the limitations/advantages of the chosen approaches.",
keywords = "Complex disorders, epistasis, LOAD, modeling, PLINK, synergy factor",
author = "Turton, {James C.} and James Bullock and Christopher Medway and Hui Shi and Kristelle Brown and Olivia Belbin and Noor Kalsheker and Carrasquillo, {Minerva M} and Dickson, {Dennis W} and {Graff Radford}, {Neill R} and Petersen, {Ronald Carl} and Younkin, {Steven G} and Kevin Morgan",
year = "2011",
doi = "10.3233/JAD-2011-110197",
language = "English (US)",
volume = "25",
pages = "635--644",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Investigating statistical epistasis in complex disorders

AU - Turton, James C.

AU - Bullock, James

AU - Medway, Christopher

AU - Shi, Hui

AU - Brown, Kristelle

AU - Belbin, Olivia

AU - Kalsheker, Noor

AU - Carrasquillo, Minerva M

AU - Dickson, Dennis W

AU - Graff Radford, Neill R

AU - Petersen, Ronald Carl

AU - Younkin, Steven G

AU - Morgan, Kevin

PY - 2011

Y1 - 2011

N2 - The missing heritability exhibited by late-onset Alzheimer's disease is unexplained and has been partly attributed to epistatic interaction. Methods available to explore this are often based on logistic regression and allow for determination of deviation from an expected outcome as a result of statistical epistasis. Three such methodologies including Synergy Factor and the PLINK modules,-epistasis and-fast-epistasis, were applied to study an epistatic interaction between interleukin-6 and interleukin-10. The models analyzed consisted of two synergistic interactions (SF ≈ 4.2 and 1.6) and two antagonistic interactions (SF ≈ 0.9 and 0.6). As with any statistical test, power to detect association is paramount; and most studies will be underpowered for the task. However, the availability of large sample sizes through genome-wide association studies make it feasible to examine approaches for determining epistatic interactions. This study documents the sample sizes needed to achieve a statistically significant outcome from each of the methods examined and discusses the limitations/advantages of the chosen approaches.

AB - The missing heritability exhibited by late-onset Alzheimer's disease is unexplained and has been partly attributed to epistatic interaction. Methods available to explore this are often based on logistic regression and allow for determination of deviation from an expected outcome as a result of statistical epistasis. Three such methodologies including Synergy Factor and the PLINK modules,-epistasis and-fast-epistasis, were applied to study an epistatic interaction between interleukin-6 and interleukin-10. The models analyzed consisted of two synergistic interactions (SF ≈ 4.2 and 1.6) and two antagonistic interactions (SF ≈ 0.9 and 0.6). As with any statistical test, power to detect association is paramount; and most studies will be underpowered for the task. However, the availability of large sample sizes through genome-wide association studies make it feasible to examine approaches for determining epistatic interactions. This study documents the sample sizes needed to achieve a statistically significant outcome from each of the methods examined and discusses the limitations/advantages of the chosen approaches.

KW - Complex disorders

KW - epistasis

KW - LOAD

KW - modeling

KW - PLINK

KW - synergy factor

UR - http://www.scopus.com/inward/record.url?scp=80052834050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052834050&partnerID=8YFLogxK

U2 - 10.3233/JAD-2011-110197

DO - 10.3233/JAD-2011-110197

M3 - Article

C2 - 21483092

AN - SCOPUS:80052834050

VL - 25

SP - 635

EP - 644

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -